Given the lack of selling since the placement, perhaps these sophisticated investors can actually see some real value in the NT prospects. They haven't cashed in so far for 60-100% profits so longer term investors perhaps
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025